- Medical School - UT Southwestern Medical School (2010-2014)
- Residency - UT Southwestern Medical Center (2014-2017), Internal Medicine
- Fellowship - University of Michigan Health System (2017-2020), Hematology Oncology
John Hancock, M.D.
- Internal Medicine - Hematology/Oncology
- Bleeding Disorders
- Hemophilia
New Patient Appointment Accepting Virtual Visits or 214-645-4673
Biography
J. Matt Hancock, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in bleeding and clotting disorders, including hemophilia, von Willebrand disease, and other nonmalignant blood disorders such as sickle cell disease.
Dr. Hancock earned his medical degree at UT Southwestern, where he also completed his residency in internal medicine. He gained advanced training in hematology and oncology through a fellowship at the University of Michigan Medical School.
Certified in hematology and internal medicine by the American Board of Internal Medicine, he joined the UT Southwestern faculty in 2023.
Dr. Hancock is a member of the American Society of Hematology, the International Society on Thrombosis and Haemostasis, the Hemostasis and Thrombosis Research Society, and the Dallas County Medical Society.
He has been a review editor for the journal Frontiers in Hematology since 2021.
Personal Note
Outside of work, Dr. Hancock enjoys food, wine, beer, travel, and the outdoors.
Education & Training
Professional Associations & Affiliations
- American Society of Hematology
- Dallas County Medical Society
- Hemostasis and Thrombosis Research Society
- International Society on Thrombosis and Haemostasis
Honors & Awards
- Third Prize 2022, UT Health/Memorial Hermann Texas Medical Center Quality Symposium
- Haemophilia Academy 2021
- Travel Award 2018, Pre-American Society of Hematology Trainee Workshop, Hemostasis and Thrombosis Research Society
Books & Publications
-
Books
-
Stem cell biology and hematopoiesis in Hematology Board Review: Blueprint Study Guide and Q&A
Jones M, King R, Hancock JM, Ghosh M (2018), New York, Demos Medical Publishing/Springer Publishing Company
-
Stem cell biology and hematopoiesis in Hematology Board Review: Blueprint Study Guide and Q&A
-
Publications
-
An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease.
Hancock JM, Escobar MA, Expert review of hematology 2023 Mar 16 3 157-161 -
Histoplasmosis-Induced Hemophagocytic Syndrome: A Case Series and Review of the Literature.
Townsend JL, Shanbhag S, Hancock J, Bowman K, Nijhawan AE Open forum infectious diseases 2015 Apr 2 2 ofv055
-
An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease.
Research
- Genetics of von Willebrand disease
Clinical Focus
- Bleeding Disorders
- Hemophilia
- Sickle Cell Disease
- Von Willebrand Disease
Results: 1 Locations
New Patient Appointment Accepting Virtual Visits or 214-645-4673